Annual Report 2019

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2019 104 The United Laboratories International Holdings Limited Annual Report 2019 14. FIVE HIGHEST PAID EMPLOYEES For the years ended 31 December 2019 and 2018, all the five highest paid individuals of the Group are directors of the Company, details of which are included in Note 13. 15. DIVIDENDS 2019 2018 RMB’000 RMB’000 Dividends for ordinary shareholders of the Company recognised as distribution during the year 2018 final dividend RMB6 cents (2018: 2017 final dividend of RMB5 cents) per share 98,383 84,443 Subsequent to the end of the reporting period, a final dividend in respect of the year ended 31 December 2019 of RMB7 cents (2018: RMB6 cents) per ordinary share, in an aggregate amount of RMB115,151,000 (2018: RMB98,383,000), has been proposed by the directors of the Company and is subject to approval by the shareholders in the forthcoming general meeting. 16. EARNINGS PER SHARE The calculation of the basic and diluted earnings per share attributable to the owners of the Company is based on the following data: Earnings 2019 2018 RMB’000 RMB’000 Earnings for the purposes of basic earnings per share being profit for the year attributable to owners of the Company 641,764 682,928 Effect of dilutive potential ordinary shares: Effect on convertible bonds – (91,031) Earnings for the purposes of diluted earnings per share being profit for the year attributable to owners of the Company 641,764 591,897